Clinical Trial Update: Safety and Efficacy Study of Bosentan for Intermittent Claudication in Peripheral Arterial Disease [NA]

View source ↗

Summary

This update summarizes a completed clinical trial evaluating the safety and efficacy of bosentan for intermittent claudication in peripheral arterial disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: Hospital Universitario Getafe | Conditions: Peripheral Arterial Disease | NA | Status: COMPLETED